Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering Drug Prices to Evade Responsibility and Boost Their Bottom Line Big Pharma has long tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at others in the drug supply chain. Drug companies, in particular, have […]
Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall Street Expectations After 2020 Price Hikes In a final round of second quarter earnings reports, another Big Pharma giant announced they surpassed earnings expectations after hiking prices on American patients. Bristol-Myers Squibb reported sky-high profits after hiking prices on American patients earlier […]
Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A Drug Company Idea The Origins of a Big Pharma Bailout Would you be surprised to learn a controversial idea to hand Big Pharma a more than $100 billion bailout while increasing Medicare premiums and costing taxpayers billions originated with a Big Pharma company? […]
Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations After Price Hikes Two more Big Pharma giants announced Friday they surpassed earnings expectations after hiking prices on American patients. AbbVie and Merck both reported sky-high profits after hiking prices on American patients earlier this year. AbbVie Sales increased to $10.4 billion compared to […]
Brand Name Drug Companies See Soaring Profits After Hiking Prices Today, brand name drug giants AstraZeneca and Eli Lilly announced rising profits for the second quarter of 2020 – topping analysts’ expectations. AstraZeneca AstraZeneca reported a net profit of $756 million, up from $130 million for the same period a year earlier. Sales rose eight […]
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant Sanofi topped earnings expectations while continuing to hike prices, new second-quarter earnings show. Sanofi beat earnings expectations this quarter and reported a net profit jump to $8.9 billion. Strong growth this quarter was driven by eczema and asthma drug Dupixent. Strong Q2 […]
Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New second quarter earnings reports released yesterday from Big Pharma giants Pfizer and Amgen demonstrate yet again that price hikes continue to support big time profits for brand name drug companies. Both pharmaceutical manufacturers beat Wall Street expectations for the second quarter of 2020. Pfizer […]
Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers, Support from Drug Companies and Poison Pill Provision On Friday, the administration announced the revival of a policy known as the Rebate Rule via executive order. The Rebate Rule was previously withdrawn by the White House amid concerns that the measure would hike premiums […]
HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and Conservative Commentators Raised Doubts on Premium Increases, Cost to Taxpayers and Bailout for Big Pharma Reports this week indicate the administration may reboot a policy known as the Rebate Rule. The Rebate Rule was previously withdrawn by the White House amid concerns, on both sides of the […]
Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Prices New earnings reports for the second quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices. On Tuesday, Big Pharma drug company Novartis announced it bested earnings forecasts for the second quarter after hiking prices […]